SectorPharmaceutical
Established Date--
Listing Date09/07/1981
ExchangeNew York Stock Exchange
Full-time Employees69505
Fiscal Year Ends31/12
Security TypeDepository Receipts (Ordinary Shares)
Office addressNovo Alle 1, DK-2880 Bagsverd, Denmark
BusinessDevelopment and sales of diabetes medical products
IntroductionNovo Nordisk A/S was established in 1989 by the merger of two Danish companies, Nordisk Gentofte A/S and Novo Industri A/S. The company is a global healthcare company and a world leader in obesity and diabetes care, manufacturing and marketing of pharmaceutical products including GLP-1 receptor agonists and modern insulins. Headquartered in Denmark, it operates in about 80 countries and sells its products in about 170 countries.
